Mercè Jodar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mercè Jodar has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Sol Fernandez-Gonzalo
Critical Care Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain
16 shared publications - Guillem Navarra-Ventura
University of the Balearic Islands
6 shared publications - Diego Palao
Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Plaça Torre de l'Aigua, s/n Sabadell, 08208, Spain, +34 937458376
5 shared publications - Lluis Blanch
CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
5 shared publications - Esther Pousa
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), ISCIII, Madrid, Spain
4 shared publications Marc Turon
Research Department, Fundació Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT), Universitat Autònoma de Barcelona, Parc Taulí, Sabadell, Barcelona, Spain
4 shared publications
Latest Publications
- 30 August 2026
- Published by Grupo Editorial Psicofundación in Psicothema
- Vol. 38 (4) , 213-223
Psychometric Evaluation and Normative Framework for the Movie for the Assessment of Social Cognition in Spanish-Speaking Adults
Background: The Movie for the Assessment of Social Cognition-Spanish (MASC-SP) assesses general mentalization performance and associated error patterns: over-mentalization, under-mentalization, and non-mentalization. This study aims to provide the first large-scale psychometric evaluation and normative framework for MASC-SP scores in Spanish-speaking adults. Method: 2,582 healthy adults completed the MASC-SP via a secure online platform. The psychometric evaluation included factor analysis, measurement invariance, internal consistency, and floor/ceiling effects. Normative data were stratified by demographic variables and are presented as empirical percentiles and z-scores. Results: MASC-SP scores showed a predominantly unifactorial structure, with internal consistency ranging from questionable to good. A floor effect was observed in the non-mentalization error score. Female participants and those with a university education scored higher and made fewer errors than men and those without a university education. Age-related results were heterogeneous. Conclusions: The results support interpreting the MASC-SP total score as a robust quantitative indicator of general mentalization performance and the error scores as secondary qualitative indicators of different error patterns. Normative data stratified by sex and educational level provide a useful reference for research and clinical settings. However, norms stratified by age groups should be applied with caution due to their questionable clinical and developmental relevance.
- 30 August 2026
- Published by Grupo Editorial Psicofundación in Psicothema
- Vol. 38 (4) , 213-223
Psychometric Evaluation and Normative Framework for the Movie for the Assessment of Social Cognition in Spanish-Speaking Adults
Background: The Movie for the Assessment of Social Cognition-Spanish (MASC-SP) assesses general mentalization performance and associated error patterns: over-mentalization, under-mentalization, and non-mentalization. This study aims to provide the first large-scale psychometric evaluation and normative framework for MASC-SP scores in Spanish-speaking adults. Method: 2,582 healthy adults completed the MASC-SP via a secure online platform. The psychometric evaluation included factor analysis, measurement invariance, internal consistency, and floor/ceiling effects. Normative data were stratified by demographic variables and are presented as empirical percentiles and z-scores. Results: MASC-SP scores showed a predominantly unifactorial structure, with internal consistency ranging from questionable to good. A floor effect was observed in the non-mentalization error score. Female participants and those with a university education scored higher and made fewer errors than men and those without a university education. Age-related results were heterogeneous. Conclusions: The results support interpreting the MASC-SP total score as a robust quantitative indicator of general mentalization performance and the error scores as secondary qualitative indicators of different error patterns. Normative data stratified by sex and educational level provide a useful reference for research and clinical settings. However, norms stratified by age groups should be applied with caution due to their questionable clinical and developmental relevance.
- Open Access
- 3 July 2026
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 21 (1)
Cognitive function in adult NF1 patients without other cognitive disorders: a cross-sectional study
Background: Neurofibromatosis type 1 (NF1) is associated with cognitive impairments affecting attention, executive function, memory, visuospatial abilities, and processing speed, which are well described in children and adolescents and may interfere with daily functioning. In contrast, cognitive functioning in adults with NF1 remains less clearly defined, particularly in individuals without previous neurological or psychological conditions affecting cognitive functioning that may confound neuropsychological performance. This cross-sectional study aimed to characterize cognitive performance across multiple domains in adults with NF1 and to examine the relationship between cognitive performance and psychological and clinical variables. Results: Eighty-seven adults with NF1 and no intellectual disability or previously diagnosed cognitive or psychiatric disorders underwent standardized neuropsychological assessment across seven cognitive domains commonly reported as affected in NF1, particularly in pediatric populations: visual memory, verbal memory, executive function, attention, visuospatial ability, working memory, and visuomotor speed. Participants also completed questionnaires assessing sociodemographic and psychological variables. Cognitive performance was standardized using age-adjusted normative Z-scores. Adults with NF1 performed below the normative mean across several cognitive domains relative to age-adjusted Spanish reference data. Executive function showed clinically significant impairment (z = −2.267), whereas attention showed low-average performance (z = −1.171). Although attention was associated with skin severity and visuospatial ability with depressive symptoms ( p < 0.05), these associations were not significant after correction for multiple comparisons. Conclusions: These findings suggest a consistent pattern of cognitive underperformance in adults with NF1 without previous neurological or psychological conditions affecting cognitive functioning, supporting the presence of a specific cognitive vulnerability associated with the condition. Although some clinical factors showed associations with specific cognitive domains, these relations were small and did not remain significant after correction for multiple comparisons. These results highlight the importance of routine cognitive assessment and targeted cognitive and psychosocial support strategies, including their integration into genetic counseling, to improve clinical follow-up and patient care.
- 3 July 2026
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 21 (1)
Open AccessCognitive function in adult NF1 patients without other cognitive disorders: a cross-sectional study
Background: Neurofibromatosis type 1 (NF1) is associated with cognitive impairments affecting attention, executive function, memory, visuospatial abilities, and processing speed, which are well described in children and adolescents and may interfere with daily functioning. In contrast, cognitive functioning in adults with NF1 remains less clearly defined, particularly in individuals without previous neurological or psychological conditions affecting cognitive functioning that may confound neuropsychological performance. This cross-sectional study aimed to characterize cognitive performance across multiple domains in adults with NF1 and to examine the relationship between cognitive performance and psychological and clinical variables. Results: Eighty-seven adults with NF1 and no intellectual disability or previously diagnosed cognitive or psychiatric disorders underwent standardized neuropsychological assessment across seven cognitive domains commonly reported as affected in NF1, particularly in pediatric populations: visual memory, verbal memory, executive function, attention, visuospatial ability, working memory, and visuomotor speed. Participants also completed questionnaires assessing sociodemographic and psychological variables. Cognitive performance was standardized using age-adjusted normative Z-scores. Adults with NF1 performed below the normative mean across several cognitive domains relative to age-adjusted Spanish reference data. Executive function showed clinically significant impairment (z = −2.267), whereas attention showed low-average performance (z = −1.171). Although attention was associated with skin severity and visuospatial ability with depressive symptoms ( p < 0.05), these associations were not significant after correction for multiple comparisons. Conclusions: These findings suggest a consistent pattern of cognitive underperformance in adults with NF1 without previous neurological or psychological conditions affecting cognitive functioning, supporting the presence of a specific cognitive vulnerability associated with the condition. Although some clinical factors showed associations with specific cognitive domains, these relations were small and did not remain significant after correction for multiple comparisons. These results highlight the importance of routine cognitive assessment and targeted cognitive and psychosocial support strategies, including their integration into genetic counseling, to improve clinical follow-up and patient care.
- Open Access
- 6 June 2025
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 20 (1) , 1-12
The association of body image with quality of life, psychological assistance and social support in neurofibromatosis type 1 patients: a cross-sectional study
Background: Neurofibromatosis type 1 is a genetic disease with an autosomal dominant pattern. One of its clinical features is the presence of disfiguring neurofibromas. Most adults with Neurofibromatosis type 1 have visible neurofibromas depending on the severity of their skin related clinic that can affect their body image, and body image influencing psychological assistance and social support. This research explored Body image, the negative perception of the appearance of neurofibromas and skin severity in Neurofibromatosis type 1 patients; assessed its association with quality of life; and the role of social support and psychological assistance. Results: Two hundred five patients with Neurofibromatosis type 1 (16–74 years) were included in the study. They responded to questionnaires about their quality of life, body image and other sociodemographic data. Correlations and simple and multiple regressions were used to assess the relationships between variables. The results showed that body image problems increased if Neurofibromatosis type 1 patients were concerned about the aspects of their neurofibromas (B = 4.544; p < 0.001) and if they had severe skin conditions (B = 4.262; p < .001). Despite this, statistical analysis showed that only body image impairments reduced quality of life by 0.605 ( p < 0.001), while skin severity and the negative perception of the appearance of neurofibromas were not clearly related. Patients with body image impairments are more likely to seek psychological assistance (ρ = 0.218; p < 0.01), but they are less likely to report having social support. The results also showed that when patients with Neurofibromatosis type 1 retrieved they have social support (ρ = -0.210, p < 0.01) or they inform doing psychological assistance (ρ = -0.238; p < 0.001), they have lower quality of life. Conclusion: Body image concerns, rather than skin severity, are a key feature for detecting quality of life impairments in these patients. When healthcare professionals detect body image impairments, it is crucial for them to collaborate with patients and either provide or refer them to psychological interventions. This approach helps improve social support, enabling patients to benefit from both their professional and personal environments.
- 6 June 2025
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 20 (1) , 1-12
Open AccessThe association of body image with quality of life, psychological assistance and social support in neurofibromatosis type 1 patients: a cross-sectional study
Background: Neurofibromatosis type 1 is a genetic disease with an autosomal dominant pattern. One of its clinical features is the presence of disfiguring neurofibromas. Most adults with Neurofibromatosis type 1 have visible neurofibromas depending on the severity of their skin related clinic that can affect their body image, and body image influencing psychological assistance and social support. This research explored Body image, the negative perception of the appearance of neurofibromas and skin severity in Neurofibromatosis type 1 patients; assessed its association with quality of life; and the role of social support and psychological assistance. Results: Two hundred five patients with Neurofibromatosis type 1 (16–74 years) were included in the study. They responded to questionnaires about their quality of life, body image and other sociodemographic data. Correlations and simple and multiple regressions were used to assess the relationships between variables. The results showed that body image problems increased if Neurofibromatosis type 1 patients were concerned about the aspects of their neurofibromas (B = 4.544; p < 0.001) and if they had severe skin conditions (B = 4.262; p < .001). Despite this, statistical analysis showed that only body image impairments reduced quality of life by 0.605 ( p < 0.001), while skin severity and the negative perception of the appearance of neurofibromas were not clearly related. Patients with body image impairments are more likely to seek psychological assistance (ρ = 0.218; p < 0.01), but they are less likely to report having social support. The results also showed that when patients with Neurofibromatosis type 1 retrieved they have social support (ρ = -0.210, p < 0.01) or they inform doing psychological assistance (ρ = -0.238; p < 0.001), they have lower quality of life. Conclusion: Body image concerns, rather than skin severity, are a key feature for detecting quality of life impairments in these patients. When healthcare professionals detect body image impairments, it is crucial for them to collaborate with patients and either provide or refer them to psychological interventions. This approach helps improve social support, enabling patients to benefit from both their professional and personal environments.
- Open Access
- 1 April 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (4) , 647-650
Cognitive Reserve and Cluster Analysis: New Pieces in the Puzzle of Cognitive Impairment after ICU?
- 1 April 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (4) , 647-650
Open AccessCognitive Reserve and Cluster Analysis: New Pieces in the Puzzle of Cognitive Impairment after ICU?
- Open Access
- 17 June 2024
- Published by Taylor & Francis in European Journal of Psychotraumatology
- Vol. 15 (1) , 2363654
Occurrence, co-occurrence and persistence of symptoms of depression and post-traumatic stress disorder in survivors of COVID-19 critical illness
Background: Intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) are associated with psychological distress and trauma. The COVID-19 pandemic brought with it a series of additional long-lasting stressful and traumatic experiences. However, little is known about comorbid depression and post-traumatic stress disorder (PTSD).Objective: To examine the occurrence, co-occurrence, and persistence of clinically significant symptoms of depression and PTSD, and their predictive factors, in COVID-19 critical illness survivors.Method: Single-centre prospective observational study in adult survivors of COVID-19 with ≥24 h of ICU admission. Patients were assessed one and 12 months after ICU discharge using the depression subscale of the Hospital Anxiety and Depression Scale and the Davidson Trauma Scale. Differences in isolated and comorbid symptoms of depression and PTSD between patients with and without IMV and predictors of the occurrence and persistence of symptoms of these mental disorders were analysed.Results: Eighty-nine patients (42 with IMV) completed the 1-month follow-up and 71 (34 with IMV) completed the 12-month follow-up. One month after discharge, 29.2% of patients had symptoms of depression and 36% had symptoms of PTSD; after one year, the respective figures were 32.4% and 31%. Coexistence of depressive and PTSD symptoms accounted for approximately half of all symptomatic cases. Isolated PTSD symptoms were more frequent in patients with IMV (p≤.014). The need for IMV was associated with the occurrence at one month (OR = 6.098, p = .005) and persistence at 12 months (OR = 3.271, p = .030) of symptoms of either of these two mental disorders.Conclusions: Comorbid depressive and PTSD symptoms were highly frequent in our cohort of COVID-19 critical illness survivors. The need for IMV predicted short-term occurrence and long-term persistence of symptoms of these mental disorders, especially PTSD symptoms. The specific role of dyspnea in the association between IMV and post-ICU mental disorders deserves further investigation.Trial registration: ClinicalTrials.gov identifier: NCT04422444.
- 17 June 2024
- Published by Taylor & Francis in European Journal of Psychotraumatology
- Vol. 15 (1) , 2363654
Open AccessOccurrence, co-occurrence and persistence of symptoms of depression and post-traumatic stress disorder in survivors of COVID-19 critical illness
Background: Intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) are associated with psychological distress and trauma. The COVID-19 pandemic brought with it a series of additional long-lasting stressful and traumatic experiences. However, little is known about comorbid depression and post-traumatic stress disorder (PTSD).Objective: To examine the occurrence, co-occurrence, and persistence of clinically significant symptoms of depression and PTSD, and their predictive factors, in COVID-19 critical illness survivors.Method: Single-centre prospective observational study in adult survivors of COVID-19 with ≥24 h of ICU admission. Patients were assessed one and 12 months after ICU discharge using the depression subscale of the Hospital Anxiety and Depression Scale and the Davidson Trauma Scale. Differences in isolated and comorbid symptoms of depression and PTSD between patients with and without IMV and predictors of the occurrence and persistence of symptoms of these mental disorders were analysed.Results: Eighty-nine patients (42 with IMV) completed the 1-month follow-up and 71 (34 with IMV) completed the 12-month follow-up. One month after discharge, 29.2% of patients had symptoms of depression and 36% had symptoms of PTSD; after one year, the respective figures were 32.4% and 31%. Coexistence of depressive and PTSD symptoms accounted for approximately half of all symptomatic cases. Isolated PTSD symptoms were more frequent in patients with IMV (p≤.014). The need for IMV was associated with the occurrence at one month (OR = 6.098, p = .005) and persistence at 12 months (OR = 3.271, p = .030) of symptoms of either of these two mental disorders.Conclusions: Comorbid depressive and PTSD symptoms were highly frequent in our cohort of COVID-19 critical illness survivors. The need for IMV predicted short-term occurrence and long-term persistence of symptoms of these mental disorders, especially PTSD symptoms. The specific role of dyspnea in the association between IMV and post-ICU mental disorders deserves further investigation.Trial registration: ClinicalTrials.gov identifier: NCT04422444.
- Open Access
- 1 April 2024
- Published by SAGE Publications in Women's Health Reports
- Vol. 5 (1) , 984-996
Eye Movement Desensitization and Reprocessing: Efficacy in Improving Clinical, Neuropsychological, and Quality of Life in Women Victims of Violence
The number of female victims of violence has significantly increased in recent years, resulting in physical, mental, and social damage. To determine the effectiveness of the eye movement desensitization and reprocessing (EMDR) psychotherapeutic model compared with narrative exposure therapy (NET) as treatments for clinical improvement, neuropsychological outcomes, and quality of life in women who have experienced violence. A randomized experimental study was conducted, involving 120 women exposed to physical, psychological, and sexual violence, who were assigned to either an EMDR or NET group. An extensive battery of clinical, neuropsychological, and quality of life tests was administered both before and after a 10-session therapeutic intervention. Compared with the group of women treated with NET, the group of women who received EMDR therapy, exposed to physical, psychological, and sexual violence, achieved a greater decrease in anxiety (p = 0.001), depression (p = 0.001), and post-traumatic symptoms (p = 0.002). Additionally, there was an increase in the quality of life index (p = 0.001), performance in working memory (p = 0.000), and executive functioning tests (p = 0.000), compared with NET. EMDR proved to be more effective compared with NET in reducing post-traumatic clinical symptoms, increasing the level of quality of life, and enhancing cognitive performance in women affected by gender-based violence. Additionally, it demonstrated independence in therapeutic response across most estimated sociodemographic factors, making it a therapy with broader therapeutic reach in the community of Ecuadorian women.
- 1 April 2024
- Published by SAGE Publications in Women's Health Reports
- Vol. 5 (1) , 984-996
Open AccessEye Movement Desensitization and Reprocessing: Efficacy in Improving Clinical, Neuropsychological, and Quality of Life in Women Victims of Violence
The number of female victims of violence has significantly increased in recent years, resulting in physical, mental, and social damage. To determine the effectiveness of the eye movement desensitization and reprocessing (EMDR) psychotherapeutic model compared with narrative exposure therapy (NET) as treatments for clinical improvement, neuropsychological outcomes, and quality of life in women who have experienced violence. A randomized experimental study was conducted, involving 120 women exposed to physical, psychological, and sexual violence, who were assigned to either an EMDR or NET group. An extensive battery of clinical, neuropsychological, and quality of life tests was administered both before and after a 10-session therapeutic intervention. Compared with the group of women treated with NET, the group of women who received EMDR therapy, exposed to physical, psychological, and sexual violence, achieved a greater decrease in anxiety (p = 0.001), depression (p = 0.001), and post-traumatic symptoms (p = 0.002). Additionally, there was an increase in the quality of life index (p = 0.001), performance in working memory (p = 0.000), and executive functioning tests (p = 0.000), compared with NET. EMDR proved to be more effective compared with NET in reducing post-traumatic clinical symptoms, increasing the level of quality of life, and enhancing cognitive performance in women affected by gender-based violence. Additionally, it demonstrated independence in therapeutic response across most estimated sociodemographic factors, making it a therapy with broader therapeutic reach in the community of Ecuadorian women.
- 1 July 2023
- Published by Elsevier in Spanish Journal of Psychiatry and Mental Health
- Vol. 16 (3) , 169-174
Social cognition in first-episode schizophrenia/schizoaffective disorder patients
- 1 July 2023
- Published by Elsevier in Spanish Journal of Psychiatry and Mental Health
- Vol. 16 (3) , 169-174
Social cognition in first-episode schizophrenia/schizoaffective disorder patients
- Open Access
- 1 February 2023
- Published by SAGE Publications in Women's Health Reports
- Vol. 4 (1) , 448-460
Clinical Neuropsychological Profile and Quality of Life in Women Who Have Suffered Gender-Based Violence
Background: This research characterizes the clinical and neuropsychological profiles and the quality of life in a group of Ecuadorian women who suffered physical violence, psychological violence, or sexual violence, exploring their relationships with sociodemographic factors. Methods: A battery of tests were used to explore the clinical and neuropsychological functions and quality of life in 120 participants who were selected from a population affected by violence. Results: Sixty percent of the participants showed clinical anxiety, 26.7% clinical depression, 40% post-traumatic stress disorder symptoms, 15% moderate personality disorder, and 51.7% a low quality-of-life index. Their Z-scores in the neuropsychological domains evaluated were verbal memory (Rey Auditory Verbal Learning Test = −1.35), working memory (Digits = −1.67), attention (D2 = −1.24), processing speed (Coding = −1.33; Trail Making Test A = 1.81), and executive function (Trail Making Test B = −1.15; Stroop = −0.20; verbal-semantic fluency test = 0.05; verbal fluency test = −1.23). Conclusions: The majority of women who suffered gender-based violence presented clinical levels of anxiety, depression, and post-traumatic symptoms. The cognitive functions with lower scores ( Z < −1.5) were working memory and processing speed, mediated by education factor.
- 1 February 2023
- Published by SAGE Publications in Women's Health Reports
- Vol. 4 (1) , 448-460
Open AccessClinical Neuropsychological Profile and Quality of Life in Women Who Have Suffered Gender-Based Violence
Background: This research characterizes the clinical and neuropsychological profiles and the quality of life in a group of Ecuadorian women who suffered physical violence, psychological violence, or sexual violence, exploring their relationships with sociodemographic factors. Methods: A battery of tests were used to explore the clinical and neuropsychological functions and quality of life in 120 participants who were selected from a population affected by violence. Results: Sixty percent of the participants showed clinical anxiety, 26.7% clinical depression, 40% post-traumatic stress disorder symptoms, 15% moderate personality disorder, and 51.7% a low quality-of-life index. Their Z-scores in the neuropsychological domains evaluated were verbal memory (Rey Auditory Verbal Learning Test = −1.35), working memory (Digits = −1.67), attention (D2 = −1.24), processing speed (Coding = −1.33; Trail Making Test A = 1.81), and executive function (Trail Making Test B = −1.15; Stroop = −0.20; verbal-semantic fluency test = 0.05; verbal fluency test = −1.23). Conclusions: The majority of women who suffered gender-based violence presented clinical levels of anxiety, depression, and post-traumatic symptoms. The cognitive functions with lower scores ( Z < −1.5) were working memory and processing speed, mediated by education factor.
- Open Access
- 25 April 2022
- Published by Springer Nature in Research Square
Clinical-neuropsychological profile and quality of life in women who have suffered gender-based violence
The authors have requested that this preprint be removed from Research Square.
- 25 April 2022
- Published by Springer Nature in Research Square
Open AccessClinical-neuropsychological profile and quality of life in women who have suffered gender-based violence
The authors have requested that this preprint be removed from Research Square.
- Open Access
- 29 November 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (12) , 1260
Virtual Reality-Based Early Neurocognitive Stimulation in Critically Ill Patients: A Pilot Randomized Clinical Trial
This study focuses on the application of a non-immersive virtual reality (VR)-based neurocognitive intervention in critically ill patients. Our aim was to assess the feasibility of direct outcome measures to detect the impact of this digital therapy on patients’ cognitive and emotional outcomes. Seventy-two mechanically ventilated adult patients were randomly assigned to the “treatment as usual” (TAU, n = 38) or the “early neurocognitive stimulation” (ENRIC, n = 34) groups. All patients received standard intensive care unit (ICU) care. Patients in the ENRIC group also received adjuvant neurocognitive stimulation during the ICU stay. Outcome measures were a full neuropsychological battery and two mental health questionnaires. A total of 42 patients (21 ENRIC) completed assessment one month after ICU discharge, and 24 (10 ENRIC) one year later. At one-month follow-up, ENRIC patients had better working memory scores (p = 0.009, d = 0.363) and showed up to 50% less non-specific anxiety (11.8% vs. 21.1%) and depression (5.9% vs. 10.5%) than TAU patients. A general linear model of repeated measures reported a main effect of group, but not of time or group–time interaction, on working memory, with ENRIC patients outperforming TAU patients (p = 0.008, ηp2 = 0.282). Our results suggest that non-immersive VR-based neurocognitive stimulation may help improve short-term working memory outcomes in survivors of critical illness. Moreover, this advantage could be maintained in the long term. An efficacy trial in a larger sample of participants is feasible and must be conducted.
- 29 November 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (12) , 1260
Open AccessVirtual Reality-Based Early Neurocognitive Stimulation in Critically Ill Patients: A Pilot Randomized Clinical Trial
This study focuses on the application of a non-immersive virtual reality (VR)-based neurocognitive intervention in critically ill patients. Our aim was to assess the feasibility of direct outcome measures to detect the impact of this digital therapy on patients’ cognitive and emotional outcomes. Seventy-two mechanically ventilated adult patients were randomly assigned to the “treatment as usual” (TAU, n = 38) or the “early neurocognitive stimulation” (ENRIC, n = 34) groups. All patients received standard intensive care unit (ICU) care. Patients in the ENRIC group also received adjuvant neurocognitive stimulation during the ICU stay. Outcome measures were a full neuropsychological battery and two mental health questionnaires. A total of 42 patients (21 ENRIC) completed assessment one month after ICU discharge, and 24 (10 ENRIC) one year later. At one-month follow-up, ENRIC patients had better working memory scores (p = 0.009, d = 0.363) and showed up to 50% less non-specific anxiety (11.8% vs. 21.1%) and depression (5.9% vs. 10.5%) than TAU patients. A general linear model of repeated measures reported a main effect of group, but not of time or group–time interaction, on working memory, with ENRIC patients outperforming TAU patients (p = 0.008, ηp2 = 0.282). Our results suggest that non-immersive VR-based neurocognitive stimulation may help improve short-term working memory outcomes in survivors of critical illness. Moreover, this advantage could be maintained in the long term. An efficacy trial in a larger sample of participants is feasible and must be conducted.